Todd Rice Archives
Aug. 21, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Jul. 23, 2020—Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).
Jun. 4, 2020—The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
Sep. 12, 2019—VUMC is expanding its ECMO program from its longtime home in the Cardiovascular Intensive Care Unit (CVICU) to the Medical (MICU) and Trauma Intensive Care units.
Mar. 12, 2015—The question of what’s different about pragmatic research was aired in a well-attended panel discussion last week in Light Hall sponsored by the Vanderbilt Center for Health Services Research and the Mid-South Clinical Data Research Network (CDRN).